Last Update 16 Jun 26
Fair value Increased 4.10%G: Fuller Valuations And Dividend Policy Will Shape Balanced Share Returns
Analysts have nudged their fair value estimate for Assicurazioni Generali higher to €40.36 from €38.77, citing recent target price increases toward €40 to €71 and adjustments to assumptions around discount rates, profitability and future P/E multiples.
Analyst Commentary
Recent Street research on Assicurazioni Generali shows a mix of optimism on the company’s execution and caution around how much of that progress may already be reflected in the share price. Price targets now cluster around the €38.50 to €71 range, giving investors a sense of how differently analysts are framing potential outcomes for the stock.
Bullish Takeaways
- Bullish analysts have lifted price targets to as high as €71, which implies room above recent fair value estimates and reflects confidence in Generali’s ability to support higher valuation multiples over time.
- Several upward target revisions toward the €40 to €44 area suggest that recent execution and assumptions on profitability are viewed as solid enough to justify at least mid range outcomes within the current target spectrum.
- The move from Underperform to Neutral at one firm, with a €40 price target, signals that some previously cautious analysts now view the risk reward balance for Generali shares as more evenly set than before.
- Higher price targets combined with unchanged or more neutral ratings in some cases hint that Generali’s fundamentals are seen as resilient, even if opinions differ on how far the share price should stretch from here.
Bearish Takeaways
- Bearish analysts, including those at Morgan Stanley, have shifted to more cautious stances such as Equal Weight, indicating that Generali’s valuation is seen by some as full relative to current assumptions.
- An unchanged €38.50 price target alongside a rating downgrade shows concern that recent share price strength may already reflect much of the company’s expected execution, limiting upside if assumptions are not exceeded.
- References to valuations looking fuller in the European insurance group hint that any further re rating for Generali could require clearer signs of improved profitability or visibility on earnings quality.
- The existence of both lower and higher targets within a relatively tight cluster around current fair value suggests that incremental positive or negative surprises on execution may quickly shift sentiment on the stock.
What’s in the News for Assicurazioni Generali
- Assicurazioni Generali scheduled an Analyst/Investor Day, giving analysts and shareholders an opportunity to hear updated messaging from management on the company and its priorities. (Source: Key Developments)
- Assicurazioni Generali announced an annual dividend of €1.6400 per share, with a payment date of May 20, 2026, an ex dividend date of May 18, 2026, and a record date of May 19, 2026. (Source: Key Developments)
Valuation Changes for Assicurazioni Generali
- Fair Value, raised slightly to €40.36 from €38.77, indicating a modest uplift in the intrinsic value estimate for Assicurazioni Generali shares.
- Discount Rate, edged lower from 8.94% to 8.79%, reflecting a small reduction in the rate used to discount future cash flows.
- Revenue Growth, kept effectively unchanged at about 25.03%, showing no adjustment to the projected top line growth rate in € terms.
- Net Profit Margin, nudged higher from 4.71% to 4.72%, implying a very small improvement in expected earnings efficiency on € revenue.
- Future P/E, moved up from 13.74x to 14.22x, indicating a slightly higher valuation multiple being used for Assicurazioni Generali in the outer years.
Key Takeaways
- Digital transformation and AI integration are enhancing efficiency, pricing, and underwriting, driving operational improvements and stable margins.
- Diversification into high-growth markets and sustainability initiatives are strengthening revenue streams and improving stability and reputation.
- Heavy reliance on government bonds, underperformance in key segments, and rising capital requirements threaten margins, growth prospects, capital efficiency, and shareholder returns.
Catalysts
About Assicurazioni Generali- Provides various insurance solutions under the Generali brand in the Americas, Italy, rest of Europe, Africa, the Middle East, Asia, and the Oceania.
- Continued premium growth and margin expansion in the Life and Protection, Health & Accident segments, supported by demographic shifts like an aging population in Europe, position Generali for sustained revenue and earnings growth as long-term demand for retirement and health solutions increases.
- Strategic investments in digitalization and artificial intelligence are enhancing distribution efficiency, pricing sophistication, and underwriting capabilities, setting Generali up for future improvements in operational efficiency, lower expense ratios, and resilient net margins.
- Expansion and strong growth in Central Eastern Europe and select Asian markets are diversifying the revenue base towards higher-growth geographies, creating multi-year tailwinds for top-line and earnings growth and mitigating sluggishness in mature Western European markets.
- Ongoing focus on growing the capital-light and fee-based asset management segment, as evidenced by strong inflows and improved margins, is expected to increase net profit stability and boost return on equity over the medium to long term.
- Emphasis on sustainability in operations and investment-alongside leadership in protection products and ESG integration-should improve Generali's reputation among institutional investors, facilitate access to lower-cost capital, and help safeguard long-term profitability.
Assicurazioni Generali Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Assicurazioni Generali's revenue will grow by 25.0% annually over the next 3 years.
- Analysts assume that profit margins will shrink from 7.2% today to 4.7% in 3 years time.
- Analysts expect earnings to reach €5.3 billion (and earnings per share of €3.58) by about June 2029, up from €4.2 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as €4.3 billion.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 14.2x on those 2029 earnings, down from 15.1x today. This future PE is lower than the current PE for the GB Insurance industry at 15.1x.
- Analysts expect the number of shares outstanding to decline by 0.98% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.79%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Persistently low reinvestment yields and the company's reliance on government bonds-especially the noted increase in Italian government debt exposure-could constrain investment income and compress net margins over time if interest rates remain volatile or suppressed.
- The direct insurance channel in Italy is currently running at an undiscounted combined ratio of 105% and is less profitable than in the past, which, if not effectively turned around, may weigh on overall earnings and reduce the projected positive impact from digitalization.
- Expansion outside of Europe, particularly in Asia, is triggering higher Solvency II capital requirements due to regulatory non-equivalence, potentially depressing Solvency ratios and restricting capital efficiency, which could impair long-term earnings and hinder growth targets.
- Industry pricing cycles-especially in non-motor, health, and global corporate/commercial lines-are described as entering softer phases in certain regions, which, if not counteracted by sufficient risk premium spreads, could pressure revenue growth and operating margins.
- Cash remittances and capital release from certain markets such as Switzerland remain subdued until at least 2026–2027, constraining immediate cash flow and possibly affecting dividend/distribution policies or reinvestment capacity, thus limiting short
- to medium-term growth in shareholder returns.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of €40.36 for Assicurazioni Generali based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €71.0, and the most bearish reporting a price target of just €28.5.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €113.0 billion, earnings will come to €5.3 billion, and it would be trading on a PE ratio of 14.2x, assuming you use a discount rate of 8.8%.
- Given the current share price of €41.89, the analyst price target of €40.36 is 3.8% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Assicurazioni Generali?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.